FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2892732944> ?p ?o ?g. }

• W2892732944 endingPage "6" @default.
• W2892732944 startingPage "1" @default.
• W2892732944 abstract "Introduction . Tissue plasminogen activator (tPA) is commonly used in ischemic cerebral vascular accidents (CVAs). tPA is generally well tolerated; however, orolingual angioedema is a well-documented adverse effect. Angioedema is generally mild, transient, and unilateral but can manifest as severe, life-threatening upper airway obstruction requiring intubation. Reported incidence for all severities ranges from one to five percent, whereas reported incidence of severe cases ranges from 0.18 to 1 percent of patients receiving tPA for ischemic CVA. Angiotensin-converting enzyme (ACE) inhibitors and middle cerebral artery distribution have been associated with a higher risk of developing angioedema. The aim of this study is to evaluate the incidence of severe tPA-induced angioedema and its effects on length of stay (LOS) and death. Methods . A retrospective chart review of patients receiving tPA for ischemic CVA from January 2014 through December 2016 was conducted at a large tertiary center with Comprehensive Stroke Center designation. Subjects were eighteen or older. Baseline demographics and clinical data were collected. Results . 147 patients were included with four developing severe angioedema due to tPA resulting in an incidence of 2.72%. All four were female. The median LOS was thirty days for patients with angioedema and twelve days for those without. The survival probability was higher in the angioedema group and mean time to death was twenty-two days in the angioedema group and twenty-one days in the nonangioedema group. Twenty-five patients died, one from the angioedema group. ACE inhibitor use was found to have an OR of 7.72. Conclusion . This study found a higher incidence of severe angioedema than that reported. Development of severe angioedema increased length of stay but was not shown to worsen outcomes in regards to death. Consistent with previous studies, ACE inhibitor use was associated with a higher risk of developing angioedema." @default.
• W2892732944 created "2018-10-05" @default.
• W2892732944 creator A5002768404 @default.
• W2892732944 creator A5063313436 @default.
• W2892732944 date "2018-09-27" @default.
• W2892732944 modified "2023-09-27" @default.
• W2892732944 title "Institutional Incidence of Severe tPA-Induced Angioedema in Ischemic Cerebral Vascular Accidents" @default.
• W2892732944 cites W1963629779 @default.
• W2892732944 cites W1979427065 @default.
• W2892732944 cites W1979526365 @default.
• W2892732944 cites W1984957316 @default.
• W2892732944 cites W1992520798 @default.
• W2892732944 cites W1997755902 @default.
• W2892732944 cites W2013433754 @default.
• W2892732944 cites W2028942483 @default.
• W2892732944 cites W2070375462 @default.
• W2892732944 cites W2112328442 @default.
• W2892732944 cites W2115858038 @default.
• W2892732944 cites W2124628587 @default.
• W2892732944 cites W2149838716 @default.
• W2892732944 cites W2162080022 @default.
• W2892732944 cites W2168897254 @default.
• W2892732944 cites W2402482330 @default.
• W2892732944 cites W2410526979 @default.
• W2892732944 cites W2518417104 @default.
• W2892732944 cites W2570919643 @default.
• W2892732944 doi "https://doi.org/10.1155/2018/9360918" @default.
• W2892732944 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6180929" @default.
• W2892732944 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30363665" @default.
• W2892732944 hasPublicationYear "2018" @default.
• W2892732944 type Work @default.
• W2892732944 sameAs 2892732944 @default.
• W2892732944 citedByCount "4" @default.
• W2892732944 countsByYear W28927329442020 @default.
• W2892732944 countsByYear W28927329442021 @default.
• W2892732944 countsByYear W28927329442023 @default.
• W2892732944 crossrefType "journal-article" @default.
• W2892732944 hasAuthorship W2892732944A5002768404 @default.
• W2892732944 hasAuthorship W2892732944A5063313436 @default.
• W2892732944 hasBestOaLocation W28927329441 @default.
• W2892732944 hasConcept C120665830 @default.
• W2892732944 hasConcept C121332964 @default.
• W2892732944 hasConcept C126322002 @default.
• W2892732944 hasConcept C127413603 @default.
• W2892732944 hasConcept C141071460 @default.
• W2892732944 hasConcept C144024400 @default.
• W2892732944 hasConcept C149923435 @default.
• W2892732944 hasConcept C167135981 @default.
• W2892732944 hasConcept C27016395 @default.
• W2892732944 hasConcept C2777995640 @default.
• W2892732944 hasConcept C2778716859 @default.
• W2892732944 hasConcept C2779611605 @default.
• W2892732944 hasConcept C2780084366 @default.
• W2892732944 hasConcept C2780645631 @default.
• W2892732944 hasConcept C42219234 @default.
• W2892732944 hasConcept C61511704 @default.
• W2892732944 hasConcept C71924100 @default.
• W2892732944 hasConcept C78519656 @default.
• W2892732944 hasConcept C84393581 @default.
• W2892732944 hasConceptScore W2892732944C120665830 @default.
• W2892732944 hasConceptScore W2892732944C121332964 @default.
• W2892732944 hasConceptScore W2892732944C126322002 @default.
• W2892732944 hasConceptScore W2892732944C127413603 @default.
• W2892732944 hasConceptScore W2892732944C141071460 @default.
• W2892732944 hasConceptScore W2892732944C144024400 @default.
• W2892732944 hasConceptScore W2892732944C149923435 @default.
• W2892732944 hasConceptScore W2892732944C167135981 @default.
• W2892732944 hasConceptScore W2892732944C27016395 @default.
• W2892732944 hasConceptScore W2892732944C2777995640 @default.
• W2892732944 hasConceptScore W2892732944C2778716859 @default.
• W2892732944 hasConceptScore W2892732944C2779611605 @default.
• W2892732944 hasConceptScore W2892732944C2780084366 @default.
• W2892732944 hasConceptScore W2892732944C2780645631 @default.
• W2892732944 hasConceptScore W2892732944C42219234 @default.
• W2892732944 hasConceptScore W2892732944C61511704 @default.
• W2892732944 hasConceptScore W2892732944C71924100 @default.
• W2892732944 hasConceptScore W2892732944C78519656 @default.
• W2892732944 hasConceptScore W2892732944C84393581 @default.
• W2892732944 hasLocation W28927329441 @default.
• W2892732944 hasLocation W28927329442 @default.
• W2892732944 hasLocation W28927329443 @default.
• W2892732944 hasLocation W28927329444 @default.
• W2892732944 hasOpenAccess W2892732944 @default.
• W2892732944 hasPrimaryLocation W28927329441 @default.
• W2892732944 hasRelatedWork W127322733 @default.
• W2892732944 hasRelatedWork W1985923508 @default.
• W2892732944 hasRelatedWork W1997518038 @default.
• W2892732944 hasRelatedWork W2024457594 @default.
• W2892732944 hasRelatedWork W2086086565 @default.
• W2892732944 hasRelatedWork W2149838716 @default.
• W2892732944 hasRelatedWork W2303367200 @default.
• W2892732944 hasRelatedWork W2414613480 @default.
• W2892732944 hasRelatedWork W2433283086 @default.
• W2892732944 hasRelatedWork W3092701104 @default.
• W2892732944 hasVolume "2018" @default.
• W2892732944 isParatext "false" @default.
• W2892732944 isRetracted "false" @default.
• W2892732944 magId "2892732944" @default.

• next